Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In-hospital stroke.

David J Blacker1

  • 1Department of Neurology and Clinical Neurophysiology, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, Western Australia, Australia. davidblackermd@hotmail.com

The Lancet. Neurology
|November 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FIGHT-PD: A feasibility study of periodized boxing training for Parkinson disease.

PM & R : the journal of injury, function, and rehabilitation·2023
Same author

Preventive antibiotic therapy in acute stroke patients: A systematic review and meta-analysis of individual patient data of randomized controlled trials.

European stroke journal·2022
Same author

Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis.

Journal of thrombosis and thrombolysis·2022
Same author

Being a patient with early stage Parkinson disease: reaction to the diagnosis and management.

Internal medicine journal·2021
Same author

Comparative Assessment of the Proteolytic Stability and Impact of Poly-Arginine Peptides R18 and R18D on Infarct Growth and Penumbral Tissue Preservation Following Middle Cerebral Artery Occlusion in the Sprague Dawley Rat.

Neurochemical research·2021
Same author

Emerging cytoprotective peptide therapies for stroke.

Expert review of neurotherapeutics·2020

In-hospital strokes, affecting up to 15% of patients, are often delayed in recognition and treatment. Prompt awareness of interventional therapies like thrombolysis is crucial for improving outcomes in this vulnerable patient group.

Area of Science:

  • Neurology
  • Hospital Medicine
  • Critical Care

Background:

  • Hospital-acquired strokes account for 6.5% to 15% of all strokes.
  • These strokes often occur in patients undergoing surgery or with cardiac conditions.
  • Delays in recognition and assessment are common due to comorbidities and complex hospital practices.

Purpose of the Study:

  • To highlight the potential for rapid assessment and intervention in hospitalized patients experiencing stroke.
  • To identify risk factors and precipitating mechanisms for in-hospital strokes.
  • To emphasize the importance of physician awareness regarding interventional therapies for in-hospital stroke.

Main Methods:

  • Review of existing literature on in-hospital stroke.
  • Analysis of risk factors including specific procedures, medical history, and physiological states.

Related Experiment Videos

  • Examination of stroke subtypes, particularly embolic strokes.
  • Evaluation of interventional therapies such as thrombolysis.

    • Main Results:

    • In-hospital strokes are associated with significant mortality.
    • Embolic strokes are a common subtype.
    • Risk factors include cardiac surgery, prior stroke history, fever, and dehydration.
    • Intra-arterial thrombolysis is a feasible and safe option in selected postoperative patients.

    Conclusions:

    • Early recognition and intervention are critical for improving outcomes in patients with in-hospital strokes.
    • Interventional therapies, including thrombolysis, offer viable treatment options.
    • Increased physician awareness of these interventions can reduce assessment delays and improve patient care.